Drug
Vincristine Liposomal clinical trials
A product of Vincristine; its studies count on that page too.
How studies write it
Studies that test it under each name
Studies by the year they started
5 studies that test it; most in 2000 (2)
| Year | Studies |
|---|---|
| 2000 | 2 |
| 2011 | 1 |
| 2016 | 1 |
| 2018 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 1 · Other 4
Universität des Saarlandes (1) · M.D. Anderson Cancer Center (1) · Inex Pharmaceuticals (1) · University of Southern California (1) · St. Jude Children's Research Hospital (1)
Often tested with
Tested in the same studies.
Studies
Open first, then newest update. How each study uses Vincristine Liposomal is read from its arms, and is right about nine times in ten.
Testing it · 5
- OPTIMAL>60 / DR. CHOP, Improvement of Therapy of Elderly Patients with CD20+ DLBCL Using Rituximab Optimized and Liposomal VincristineCompletedPhase 3Universität des SaarlandesNCT01478542Written as Liposomal Vincristine
- EphB4-HSA Fusion Protein and Cytarabine /or Liposomal Vincristine in Patients With Recurrent or Refractory Acute LeukemiaTerminatedPhase 1University of Southern CaliforniaNCT03519984Written as Vincristine Liposomal
- Re-Induction Therapy for Relapsed Pediatric T-Cell Acute Lymphoblastic Leukemia or LymphomaTerminatedPhase 2St. Jude Children's Research HospitalNCT02518750Written as Liposomal vincristine
- Liposomal Vincristine for Pediatric and Adolescent Patients With Relapsed MalignanciesCompletedPhase 2M.D. Anderson Cancer CenterNCT00038207Written as Liposomal Vincristine
- Liposomal Vincristine in Treating Patients With Refractory or Relapsed Non-Hodgkin's LymphomaCompletedPhase 2Inex PharmaceuticalsNCT00006383Written as liposomal vincristine sulfate
Given in every arm · 6 — Vincristine Liposomal is usual care beside what is tested
- Venetoclax and Vincristine in Treating Patients With Relapsed or Refractory T-cell or B-cell Acute Lymphoblastic LeukemiaActive, not recruitingPhase 1/2ECOG-ACRIN Cancer Research GroupNCT03504644Written as Vincristine Liposomal
- Hyper-CVAD With Liposomal Vincristine in Acute Lymphoblastic LeukemiaCompletedPhase 2M.D. Anderson Cancer CenterNCT01319981Written as VSLI
- Combination Chemotherapy and Radiation Therapy in Treating Young Patients With Newly Diagnosed Hodgkin LymphomaCompletedPhase 3Children's Oncology GroupNCT01026220Written as liposomal vincristine sulfate
- Systemic Chemotherapy and Subtenon Carboplatin, and Local Ophthalmic Therapy in Children With Intraocular RetinoblastomaCompletedPhase 3Children's Oncology GroupNCT00072384Written as liposomal vincristine sulfate
- Vincristine, Carboplatin, and Etoposide or Observation Only in Treating Patients Who Have Undergone Surgery for Newly Diagnosed RetinoblastomaCompletedPhase 3Children's Oncology GroupNCT00335738Written as liposomal vincristine sulfate
- Obatoclax Mesylate, Vincristine Sulfate, Doxorubicin Hydrochloride, and Dexrazoxane Hydrochloride in Treating Young Patients With Relapsed or Refractory Solid Tumors, Lymphoma, or LeukemiaTerminatedPhase 1National Cancer Institute (NCI)NCT00933985Written as liposomal vincristine sulfate